Binance adds India crypto transfer checks
Binance announced new transfer verification requirements for Indian users, requiring additional sender and recipient information for crypto deposits and withdrawals from June 22, 2026.

Jon is a former international magazine editor with a strong background in business publications (print and digital) in the Middle East and Australia.
Binance announced new transfer verification requirements for Indian users, requiring additional sender and recipient information for crypto deposits and withdrawals from June 22, 2026.
Robinhood Markets added spot trading for GRAM, enabling users to buy, sell and hold the cryptocurrency directly through its retail trading platform.
Cryptocurrency exchange OKX and Intercontinental Exchange announced a proposed joint venture that will be co-chaired by former New York Governor Andrew Cuomo and focused on digital asset infrastructure.
Binance accounts for roughly 1% of its spot trading volume in euro-denominated pairs, according to data cited by CryptoQuant as the exchange navigates uncertainty around its European regulatory status.
Iluka Resources (ASX:ILU) secured its first rare earths customer via a US$155 million binding offtake agreement.
Bitmine purchased 52,203 Ethereum (CRYPTO:ETH) worth about US$90 million, increasing its holdings to 4.7% of Ethereum's total supply and moving closer to its 5% ownership target.
Arrowhead Pharmaceuticals (NASDAQ:ARWR) announced today that the European Commission has granted marketing authorization for REDEMPLO (plozasiran) as an adjunct to diet for treating adults with familial chylomicronemia syndrome (FCS).
NRx Pharmaceuticals (NASDAQ:NRXP) secured FDA authorization for a depression treatment protocol with an initial drug cost of $0.
Biotechnology firm bioAffinity Technologies (NASDAQ:BIAF) announced preclinical findings showing its novel small interfering RNA therapeutic approach selectively destroys cells from two common skin cancers that affect an estimated 5.4 million annual United States cases.
REGENXBIO (NASDAQ:RGNX) aligned with the FDA to resubmit its rare disease drug application in Q3 2026.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy